Predictive factor of secondary tricuspid regurgitation after aortic valve replacement for aortic stenosis: the importance of myocardial hypertrophy and diastolic dysfunction. 2017

Takashi Igarashi, and Masahiro Tanji, and Koki Takahashi, and Keiichi Ishida, and Satomi Sasaki, and Hitoshi Yokoyama
Department of Cardiovascular Surgery, Fukushima Medical University, Hikarigaoka 1, Fukushima, 960-1295, Japan. igao5150@fmu.ac.jp.

OBJECTIVE The aim of this study is to determine the predictors of secondary tricuspid regurgitation after aortic valve replacement for aortic stenosis. METHODS Seventy-one patients, who underwent aortic valve replacement for aortic stenosis at our institute from January 2006 to July 2011, were divided into two groups: an STR group, which included 15 patients with moderate or greater than moderate secondary tricuspid regurgitation at a follow-up visit and a control group. Echocardiography was performed before surgery, at discharge, and at a late follow-up visit (mean follow-up 36 ± 19 months, range 0-77). RESULTS Preoperatively, the number of women (p < .01), body surface area (p < .001), and relative wall thickness (0.60 ± 0.15 vs 0.71 ± 0.13, p = .022) showed significant differences between the two groups. At a follow-up visit, moderate or severe mitral regurgitation (p = .0001) and severe diastolic dysfunction (p = .003) showed significant differences between the two groups. In the Cox regression analysis, moderate or severe mitral regurgitation at follow-up (p = .038, hazard ratio 4.394, 95% CI 1.085-17.791) was the only independent predictor of secondary tricuspid regurgitation. CONCLUSIONS This study suggested that preoperative concentric myocardial hypertrophy and diastolic dysfunction were associated with development of the secondary tricuspid regurgitation at late follow-up.

UI MeSH Term Description Entries
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003971 Diastole Post-systolic relaxation of the HEART, especially the HEART VENTRICLES. Diastoles
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001021 Aortic Valve The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle. Aortic Valves,Valve, Aortic,Valves, Aortic

Related Publications

Takashi Igarashi, and Masahiro Tanji, and Koki Takahashi, and Keiichi Ishida, and Satomi Sasaki, and Hitoshi Yokoyama
October 2014, The Journal of thoracic and cardiovascular surgery,
Takashi Igarashi, and Masahiro Tanji, and Koki Takahashi, and Keiichi Ishida, and Satomi Sasaki, and Hitoshi Yokoyama
November 2023, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Takashi Igarashi, and Masahiro Tanji, and Koki Takahashi, and Keiichi Ishida, and Satomi Sasaki, and Hitoshi Yokoyama
December 2009, Circulation,
Takashi Igarashi, and Masahiro Tanji, and Koki Takahashi, and Keiichi Ishida, and Satomi Sasaki, and Hitoshi Yokoyama
March 2023, Journal of cardiovascular development and disease,
Takashi Igarashi, and Masahiro Tanji, and Koki Takahashi, and Keiichi Ishida, and Satomi Sasaki, and Hitoshi Yokoyama
May 1995, Circulation,
Takashi Igarashi, and Masahiro Tanji, and Koki Takahashi, and Keiichi Ishida, and Satomi Sasaki, and Hitoshi Yokoyama
August 2021, European heart journal. Cardiovascular Imaging,
Takashi Igarashi, and Masahiro Tanji, and Koki Takahashi, and Keiichi Ishida, and Satomi Sasaki, and Hitoshi Yokoyama
October 2011, Journal of cardiothoracic and vascular anesthesia,
Takashi Igarashi, and Masahiro Tanji, and Koki Takahashi, and Keiichi Ishida, and Satomi Sasaki, and Hitoshi Yokoyama
July 2018, The Annals of thoracic surgery,
Takashi Igarashi, and Masahiro Tanji, and Koki Takahashi, and Keiichi Ishida, and Satomi Sasaki, and Hitoshi Yokoyama
September 2005, The American journal of cardiology,
Takashi Igarashi, and Masahiro Tanji, and Koki Takahashi, and Keiichi Ishida, and Satomi Sasaki, and Hitoshi Yokoyama
September 2023, Journal of clinical medicine,
Copied contents to your clipboard!